Updates Amyloidosis Conference

Presented by ASU’s Complex Adaptive Systems Initiative (CASI)

Click here to subscribe and receive email updates on upcoming events.

Mission

To advance understanding, diagnosis, and treatment of amyloidosis through interdisciplinary collaboration, evidence-based education, and data-driven research that improves patient outcomes and drives innovation in clinical care.

Advancing Amyloidosis Care: Highlights from the 2026 Updates in Amyloidosis

On January 29–30, 2026, we had the privilege of bringing together patients, advocates, clinicians, and industry partners in Phoenix, Arizona, for the Updates in Amyloidosis Conference 2026. The impact of the 2026 Updates in Amyloidosis Conference is reflected in the engagement of nearly 130 registrants and the strong collaboration among clinicians, researchers, patients, and advocates. This meaningful exchange of knowledge and perspectives reinforced a shared commitment to advancing the understanding, diagnosis, and treatment of amyloidosis through interdisciplinary collaboration, evidence-based education, and data-driven research that improves patient outcomes and drives innovation in clinical care.

A few highlights from this year’s conference.

Vision

To become a global leader in transforming amyloidosis care by fostering a community of clinicians, researchers, and stakeholders committed to early diagnosis, equitable treatment, and continuous innovation.